Selected Summit publications

• Berghmans S, Hunt J, Roach A, Goldsmith P (2007) “Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants.”, Epilepsy Res. Jun;75(1):18-28. http://www.elsevier.com/wps/find/journaldescription.cws_home/506053/description
• Best JD, Berghmans S, Hunt JJ, Clarke SC, Fleming A, Goldsmith P, Roach AG, (2007),” Non-Associative Learning in Larval Zebrafish.”, Neuropsychopharmacology”. (20 Jun 2007), doi: 10.1038/sj.npp.1301489 http://www.nature.com/npp/index.html
• Alderton W, & Berghmans S, (2006) “Zebrafish: a versatile in vivo model for drug safety assessment.”, Drug Discovery World, Fall, 2006. http://www.ddw-online.com/
• Fleming A, Sato M, Goldsmith P, (2005), “High-throughput in vivo screening for bone anabolic compounds with zebrafish.”, J Biomol Screen. 2005 Dec;10(8):823-31. http://jbx.sagepub.com/

Recent selected zebrafish reviews

• Hill AJ, Teraoka H, Heideman W, Peterson RE.(2005) “Zebrafish as a model vertebrate for investigating chemical toxicity.”, Toxicol Sci. 86(1):6-19, http://toxsci.oxfordjournals.org/
• Lieschke GJ, Currie PD. (2007), “Animal models of human disease: zebrafish swim into view.” Nat Rev Genet. May;8(5):353-67. http://www.nature.com/nrg/index.html
• Kari G, Rodeck U, Dicker AP, (2007), “Zebrafish: an emerging model system for human disease and drug discovery”. Clin Pharmacol Ther. Jul;82(1):70-80. http://www.nature.com/clpt/index.html